137 related articles for article (PubMed ID: 30471616)
1. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
2. Establishment of induced pluripotent stem cell line CSUASOi003- A from an autosomal recessive retinitis pigmentosa patient carrying compound heterozygous mutations in CRB1 gene.
Zhou Y; Ding C; Xia S; Jing Y; Mao S; Liu J; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 Apr; 44():101742. PubMed ID: 32244200
[TBL] [Abstract][Full Text] [Related]
3. The manner of decay of genetically defective EYS gene transcripts in photoreceptor-directed fibroblasts derived from retinitis pigmentosa patients depends on the type of mutation.
Seko Y; Iwanami M; Miyamoto-Matsui K; Takita S; Aoi N; Umezawa A; Kato S
Stem Cell Res Ther; 2018 Oct; 9(1):279. PubMed ID: 30359287
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the EYS gene account for approximately 5% of autosomal recessive retinitis pigmentosa and cause a fairly homogeneous phenotype.
Littink KW; van den Born LI; Koenekoop RK; Collin RW; Zonneveld MN; Blokland EA; Khan H; Theelen T; Hoyng CB; Cremers FP; den Hollander AI; Klevering BJ
Ophthalmology; 2010 Oct; 117(10):2026-33, 2033.e1-7. PubMed ID: 20537394
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel mutations in the ortholog of Drosophila eyes shut gene (EYS) causing autosomal recessive retinitis pigmentosa.
Abd El-Aziz MM; O'Driscoll CA; Kaye RS; Barragan I; El-Ashry MF; Borrego S; Antiñolo G; Pang CP; Webster AR; Bhattacharya SS
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4266-72. PubMed ID: 20237254
[TBL] [Abstract][Full Text] [Related]
10. Fundus phenotype in retinitis pigmentosa associated with EYS mutations.
Mucciolo DP; Sodi A; Passerini I; Murro V; Cipollini F; Borg I; Pelo E; Contini E; Virgili G; Rizzo S
Ophthalmic Genet; 2018 Oct; 39(5):589-602. PubMed ID: 30153090
[TBL] [Abstract][Full Text] [Related]
11. A Novel Pair of Compound Heterozygous Mutation of
Dai C; Ren W; Wei Y; Xie C; Duan S; Li Q; Jiang L; Shi Y
Genet Test Mol Biomarkers; 2023 Aug; 27(8):258-266. PubMed ID: 37643323
[No Abstract] [Full Text] [Related]
12. Novel null mutations in the EYS gene are a frequent cause of autosomal recessive retinitis pigmentosa in the Israeli population.
Bandah-Rozenfeld D; Littink KW; Ben-Yosef T; Strom TM; Chowers I; Collin RW; den Hollander AI; van den Born LI; Zonneveld MN; Merin S; Banin E; Cremers FP; Sharon D
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4387-94. PubMed ID: 20375346
[TBL] [Abstract][Full Text] [Related]
13. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
[TBL] [Abstract][Full Text] [Related]
15. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
16. Generation of three human iPSC lines from a retinitis pigmentosa family with SLC7A14 mutation.
Li YP; Liu H; Jin ZB
Stem Cell Res; 2020 Dec; 49():102075. PubMed ID: 33207307
[TBL] [Abstract][Full Text] [Related]
17. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
[TBL] [Abstract][Full Text] [Related]
18. EYS mutation update: In silico assessment of 271 reported and 26 novel variants in patients with retinitis pigmentosa.
Messchaert M; Haer-Wigman L; Khan MI; Cremers FPM; Collin RWJ
Hum Mutat; 2018 Feb; 39(2):177-186. PubMed ID: 29159838
[TBL] [Abstract][Full Text] [Related]
19. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
[TBL] [Abstract][Full Text] [Related]
20. Generation of an iPSC line, INMi001-A, carrying the two most common USH2A mutations from a compound heterozygote with non-syndromic retinitis pigmentosa.
Sanjurjo-Soriano C; Erkilic N; Manes G; Dubois G; Hamel CP; Meunier I; Kalatzis V
Stem Cell Res; 2018 Dec; 33():228-232. PubMed ID: 30453153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
